High Blood Pressure (Hypertension) Completed Phase 4 Trials for Candesartan cilexetil (DB00796)

Also known as: HTN / Hypertension(HTN) / Hypertensive / Hypertension / High Blood Pressure / Blood High Pressure / Blood Pressure, High / High Blood Pressures / Blood pressure high / Essential (primary) hypertension / HT / HBP / Hypertension NOS / Hypertension arterial

IndicationStatusPhase
DBCOND0040789 (High Blood Pressure (Hypertension))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01734096Renal Response to Lower Body Negative Pressure in Pre-hypertensive StatesOther
NCT01611077Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgTreatment
NCT00139386Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) TrialPrevention
NCT00356395Safety and Effects of Ramipril Combined With CandesartanTreatment
NCT00348686Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)Treatment
NCT00538486A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive PatientsTreatment
NCT00775814Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.Treatment
NCT01012479Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionTreatment
NCT01682564To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart FailureTreatment
NCT01827202RAS Quantification in Patients With Aliskiren or CandesartanScreening